These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28585279)

  • 1. Serum bile acid level and fatty acid composition in Chinese children with non-alcoholic fatty liver disease.
    Lu LP; Wan YP; Xun PC; Zhou KJ; Chen C; Cheng SY; Zhang MZ; Wu CH; Lin WW; Jiang Y; Feng HX; Wang JL; He K; Cai W
    J Dig Dis; 2017 Aug; 18(8):461-471. PubMed ID: 28585279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-Specific Bile Acid Profiles in Non-Alcoholic Fatty Liver Disease.
    Fitzinger J; Rodriguez-Blanco G; Herrmann M; Borenich A; Stauber R; Aigner E; Mangge H
    Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Bile Acid Levels in Children With Nonalcoholic Fatty Liver Disease.
    Jahnel J; Zöhrer E; Alisi A; Ferrari F; Ceccarelli S; De Vito R; Scharnagl H; Stojakovic T; Fauler G; Trauner M; Nobili V
    J Pediatr Gastroenterol Nutr; 2015 Jul; 61(1):85-90. PubMed ID: 25729888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Associations between Circulating Bile Acids and the Muscle Volume in Patients with Non-alcoholic Fatty Liver Disease (NAFLD).
    Kobayashi Y; Hara N; Sugimoto R; Mifuji-Moroka R; Tanaka H; Eguchi A; Iwasa M; Hasegawa H; Iwata K; Takei Y; Taguchi O
    Intern Med; 2017; 56(7):755-762. PubMed ID: 28381740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic pattern of postprandial bile acids in paediatric non-alcoholic fatty liver disease.
    Huang J; Lin H; Liu AN; Wu W; Alisi A; Loomba R; Xu C; Xiang W; Shao J; Dong G; Zheng MH; Fu J; Ni Y
    Liver Int; 2024 Oct; 44(10):2793-2806. PubMed ID: 39082260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics and diagnostic value of serum bile acids profile in pregnant women with intrahepatic cholestasis of pregnancy and asymptomatic hypercholanemia of pregnancy].
    Gou LS; Yin X; Liu J; Suo F; Wu XY; Wang ZZ; Wang QL; Dong BL; Gu MS; Liu DY
    Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):270-278. PubMed ID: 38644273
    [No Abstract]   [Full Text] [Related]  

  • 7. NASH-related increases in plasma bile acid levels depend on insulin resistance.
    Grzych G; Chávez-Talavera O; Descat A; Thuillier D; Verrijken A; Kouach M; Legry V; Verkindt H; Raverdy V; Legendre B; Caiazzo R; Van Gaal L; Goossens JF; Paumelle R; Francque S; Pattou F; Haas JT; Tailleux A; Staels B
    JHEP Rep; 2021 Apr; 3(2):100222. PubMed ID: 33615207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease.
    Mouzaki M; Wang AY; Bandsma R; Comelli EM; Arendt BM; Zhang L; Fung S; Fischer SE; McGilvray IG; Allard JP
    PLoS One; 2016; 11(5):e0151829. PubMed ID: 27203081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegbelfermin selectively reduces secondary bile acid concentrations in patients with non-alcoholic steatohepatitis.
    Luo Y; Decato BE; Charles ED; Shevell DE; McNaney C; Shipkova P; Apfel A; Tirucherai GS; Sanyal AJ
    JHEP Rep; 2022 Jan; 4(1):100392. PubMed ID: 34977519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases.
    Sanyal AJ; Ling L; Beuers U; DePaoli AM; Lieu HD; Harrison SA; Hirschfield GM
    JHEP Rep; 2021 Jun; 3(3):100255. PubMed ID: 33898959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid profiles and classification model accuracy for inflammatory bowel disease diagnosis.
    Xu RH; Shen JN; Lu JB; Liu YJ; Song Y; Cao Y; Wang ZH; Zhang J
    Medicine (Baltimore); 2024 Jun; 103(23):e38457. PubMed ID: 38847684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [THE CONTENT OF BILE ACIDS IN THE SERUM OF PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE].
    Minnullina ZS; Kieashko SV; Sayfutdinov RG; Sayfutdinova TV
    Eksp Klin Gastroenterol; 2015; (9):24-8. PubMed ID: 26931007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
    Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
    Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.
    Adams LA; Wang Z; Liddle C; Melton PE; Ariff A; Chandraratna H; Tan J; Ching H; Coulter S; de Boer B; Christophersen CT; O'Sullivan TA; Morrison M; Jeffrey GP
    Liver Int; 2020 Jun; 40(6):1356-1365. PubMed ID: 32243703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of serum total bile acid with non-alcoholic fatty liver disease in Chinese adults: a cross sectional study.
    Zhang Z; Dai W; Weng S; Luo M; Fu J; Zadroga JA; Spolitu S; Peng D
    Lipids Health Dis; 2020 Feb; 19(1):18. PubMed ID: 32019569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fatty acid composition in French-Canadian children with non-alcoholic fatty liver disease: Effect of n-3 PUFA supplementation.
    Spahis S; Alvarez F; Dubois J; Ahmed N; Peretti N; Levy E
    Prostaglandins Leukot Essent Fatty Acids; 2015 Aug; 99():25-34. PubMed ID: 26066299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD.
    Caussy C; Hsu C; Singh S; Bassirian S; Kolar J; Faulkner C; Sinha N; Bettencourt R; Gara N; Valasek MA; Schnabl B; Richards L; Brenner DA; Hofmann AF; Loomba R
    Aliment Pharmacol Ther; 2019 Jan; 49(2):183-193. PubMed ID: 30506692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study.
    Kasai Y; Kessoku T; Tanaka K; Yamamoto A; Takahashi K; Kobayashi T; Iwaki M; Ozaki A; Nogami A; Honda Y; Ogawa Y; Kato S; Imajo K; Higurashi T; Hosono K; Yoneda M; Usuda H; Wada K; Kawanaka M; Kawaguchi T; Torimura T; Kage M; Hyogo H; Takahashi H; Eguchi Y; Aishima S; Kobayashi N; Sumida Y; Honda A; Oyamada S; Shinoda S; Saito S; Nakajima A
    Clin Transl Gastroenterol; 2022 Jul; 13(7):e00503. PubMed ID: 35616321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression.
    Nimer N; Choucair I; Wang Z; Nemet I; Li L; Gukasyan J; Weeks TL; Alkhouri N; Zein N; Tang WHW; Fischbach MA; Brown JM; Allayee H; Dasarathy S; Gogonea V; Hazen SL
    Metabolism; 2021 Mar; 116():154457. PubMed ID: 33275980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids.
    Puri P; Daita K; Joyce A; Mirshahi F; Santhekadur PK; Cazanave S; Luketic VA; Siddiqui MS; Boyett S; Min HK; Kumar DP; Kohli R; Zhou H; Hylemon PB; Contos MJ; Idowu M; Sanyal AJ
    Hepatology; 2018 Feb; 67(2):534-548. PubMed ID: 28696585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.